AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,906 Cr | ₹2,582 Cr | ₹2,244 Cr | ₹2,040 Cr | ₹0.25 Cr |
What is the latest Total Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,906 Cr |
| Mar2024 | ₹2,582 Cr |
| Mar2023 | ₹2,244 Cr |
| Mar2022 | ₹2,040 Cr |
| Mar2021 | ₹0.25 Cr |
How is Total Liabilities of AARTI PHARMALABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,906 Cr | 12.56 | |
| Mar2024 | ₹2,582 Cr | 15.07 | |
| Mar2023 | ₹2,244 Cr | 10.01 | |
| Mar2022 | ₹2,040 Cr | 815,860.00 | |
| Mar2021 | ₹0.25 Cr | - | |
Compare Total Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,409.3 Cr | 2.1% | -3.5% | -4.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 2.1% |
-3.5% |
-4.5% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses